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INTRODUCTION
Valsalva maneuver (VM) provides autonomic analyses of non-postural arterial blood pressure (BP) changes during breathing activity. Normally, hemodynamic fluctuation in VM is a quadriphasic process modulated through vagal (early phase II or phase II E ), alpha-adrenergic (mainly in late phase II or phase II L ) and beta-adrenergic (mainly in phase IV) activation, while phases I and III represent intrathoracic pressure deviations related to deep inhale and exhale, respectively ( Figure 1 ). VM mutually offers qualitative and quantitative analyses of hemodynamic responses. Visual analysis is valuable as it allows instant screening of potential sympathetic or parasympathetic failure in autonomic dysfunction.
Quantitative evaluation indirectly measures both vagal and adrenergic components of an important cardiovascular marker -arterial baroreflex sensitivity (BRS) (10, 16, 19, 20, 22, 26, 30) . Estimated in VM, BRS is a validated marker, though vagal BRS (BRSv) appears to be a more reliable than adrenergic BRS (BRSa) (17, 18, 25) .
Hemodynamic responses in VM may demonstrate reproducible patterns. In young healthy populations VM patterns appear to be associated with BRSa value and, potentially, vasomotor tone (24) . In autonomic dysfunction, VM responses are altered and capable of reflecting orthostatic intolerance (OI).
For example, there is progressive BP decline in phase II E and slow recovery in phase IV in neurogenic orthostatic hypotension (NOH), and a notable BP overshoot in phase IV in postural tachycardia syndrome (POTS) (9, 29) . Yet, definite hemodynamic patterns and associated BRS in OI have not been well elucidated. Specifically, it would be reasonable to explore postural and non-postural links of hemodynamic responses in OI. Patterning of linked to OI hemodynamic responses may enhance qualitative VM evaluation and, thus, improve the diagnosis of various autonomic disorders characterized by orthostasis. Improved VM assessment would be clinically beneficial as OI can be a substantial cause of morbidity (2, 11, 21, 23, 27) . Therefore, the present study's aim was to clarify the contribution of the VM to the diagnosis of OI. Furthermore, we sought to identify potential nonpostural markers of OI; the study specific objective was to analyze hemodynamic responses and associated BRS parameters during VM and HUT testing in pure symptomatic OI (SOI), NOH, POTS, IST, and a healthy population.
METHODS

Study design
Observational analytic study was designed in attempt to assess the association between SBP responses to VM and HUT in OI patients compared to the healthy group of population (Control). It was a prospective cohort study in regards of OI, though used as a cross-sectional study of interventions techniques (VM and HUT). The PICO model was: OI patients (Population), VM and HUT (Intervention),
Control and IST patients (Comparison) and hemodynamic responses (Outcome).
Studied Population
The study included sixty-six patients (44 females) with OI: SOI, NOH and POTS (Table 1) . NOH was defined as a reduction of systolic BP (SBP) ≥ 30 mmHg without a compensatory postural tachycardia within 3 minutes of HUT (8) . Clinical confirmation of NOH included: 1) persistent/consistent symptoms; and 2) unidentified non-neurogenic etiology (hypovolemia, medications, heart failure, excessive vasodilatation, endocrinopathy, etc.) (8, 9) . POTS was defined as a heart rate (HR) increment ≥ 30 bpm within 5 minutes of HUT, without OH but with accompanying OI symptoms (14, 31) . SOI was defined upon exclusion of HR and BP criteria for POTS and NOH, but manifested non-neuropathic OI symptoms (e.g., lightheadedness, vertigo, palpitations, dyspnea and near syncope). Additionally, IST patients (n=7; 6 females) were studied to compare POTS with non-postural tachycardia. IST was defined as resting sinus tachycardia > 100 bpm (23) . All patients were compared to a Control group of 107 healthy participants (67 females). Exclusion criteria for the Control group included any one of the following: i) exceeded 1 point each Composite Autonomic Severity Score (CASS) index (sudomotor, cardiovagal or adrenergic) complied from the Autonomic Reflex Screen; ii) pregnancy or lactation, iii) clinical autonomic dysfunction, iv) clinically significant coronary artery disease, v) usage of medications which could interfere with testing of autonomic function, and vi) failure of other organ systems or systemic illness that could affect autonomic function or the participant's ability to cooperate. A neurologist performed all the clinical evaluations and diagnoses. This study was approved by the Health Science Research Board at the University of Western Ontario.
Autonomic Tests
In one visit all participants performed standardized tests of the Autonomic Reflex Screen with the next sequence: 1) quantitative sudomotor axon reflex; 2) deep breathing testing; 3) VM; and 4) HUT.
Autonomic study was started with an instruction to be relaxed and silent as long as possible during 20-min rest at the supine position. The results of Autonomic Reflex Screen were converted to the CASS to detect and quantify possible dysautonomia (19, 20, 22) . Throughout all tests, beat-to-beat BP and HR were continuously measured using a BYEME Nexfin device (Amsterdam, The Netherlands) and an electrocardiography (ECG) device (Model 3000 Cardiac Trigger Monitor, IVY Biomedical Systems, Inc., Branford, CT) with ECG electrodes (Ambu® Blue Sensor SP, Glen Burnie, MD), respectively. All recordings were made using WR TestWorks™ software (WR Medical Electronics Co., Stillwater, MN). Waveforms of the hemodynamic responses to VM were analyzed with Spike 2 Version 7 software (Cambridge Electronic Design Ltd).
VM: Following supine rest after deep breathing testing (5-min at minimum but till the circulatory stability), participants rested quietly in the supine position for an additional one minute while "VM baseline" recordings were acquired for further measuring as averaged BP and HR. Following VM baseline, patients were instructed to inhale deeply and subsequently exhale through a bulge with an air leak (to ensure an open glottis) and to maintain an expiratory pressure of 40 mmHg for 15 s as a standard to yield the most reproducible results (3, 22) . Participants practiced series of VM to perform breathing at required level. As a standard, our VM analysis required 2 successful VM trails separated by a 2-min rest. VM trails were considered successful if the instructions were followed. A Valsalva ratio 
Experimental calculations
Additionally, we proposed evaluating α-and β-adrenergic components of BRSa discretely as α-BRSa and β-BRSa. The primary purpose in analyzing α and β components separately was that adrenergic insufficiency of one component (e.g., alpha) may be concealed in total BRSa (e.g., BRSa 1 ) by a relative hyper-response of complementary adrenergic limb (e.g., beta). Discrete BRSa evaluation was based on evidences of a mainly α-adrenergic response in phase II E and a mainly β-adrenergic response in phase IV (22, 28) . Therefore, parameters of α-BRSa were represented by phase II E (C and t 2 ), parameters of β-
BRSa -by phase IV (D and PRT).
Calculations of α-and β-BRSa were based on trigonometric function "cosine" to reflect SBP "rise over horizontal run" equivalently to the "slope" calculations for BRSv. In this manner, α-adrenergic SBP "rise C" over "run t 2 " was principally reflected by adjusted hypotenuse kȳ, 
Statistical Analysis
Hemodynamic, BRS, and patient characteristic data were compared between groups using the one-way ANOVA model with a Bonferroni Post-Hoc analysis to reveal significant differences between groups.
Repeated measures ANOVA were applied to estimate significance of certain factors (within and between the subjects) associated with the SBP patterns observed in both VM trails. Correlation analysis with a
Pearson's test was used to determine significant relationships between VM and HUT hemodynamic reductions. All tests were two-tailed and a p-value of < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS statistical software, version 21 for Windows (SPSS Inc, Chicago, IL).
RESULTS
Neurogenic orthostatic hypotension
Main characteristics of population and autonomic findings. NOH patients were significantly older than individuals of all other groups (p<0.001; Table 1 ). Half of our NOH population manifested chronic autonomic failure due to Parkinson's disease (n = 2), multiple system atrophy (n = 10) and pure autonomic failure (n = 6). One NOH patient with multiple system atrophy and two with pure autonomic failure could not complete the second VM trail. The CASS in NOH patients differed from all groups due to higher cardiovagal and adrenergic indices (p<0.01). Compared to Control and POTS, NOH had also higher sudomotor index (Table 1) .
Quantitative HUT and VM analyses Cardiovagal alterations in HUT (∆HR) and VM (VR) were significantly lower in NOH compared to the others groups ( Table 2 ). There were no significant differences in BRSv (VM) between any of the groups ( Table 2 ). As we did expect BRSv in NOH to be significantly different from Control given the differences in the VR and Δ HR, we analyzed potential impact of dysautonomia type, such as pre-and postganglionic impairment in multiple system atrophy and pure autonomic failure respectfully (13) . The results of these NOH subgroups revealed that BRSv values among the groups were still insignificant (p>0.05). In NOH, ΔHR correlated to BRSv. Only within NOH and Control groups did the postural and non-postural cardiovagal alterations (∆HR and VR) correlated. Both low VR and ΔHR demonstrated links between α-BRSa but not between β-BRSa (Table 5 ; Figure 2 ).
Not only did a lack of phase II L indicate BRSa failure, but it also equally complicated BRSa 1 and α-BRSa evaluations, making these calculations impossible in 40% of NOH patients. Additionally, BRSa 1 was compromised when "PRT" was absent (impossible in 20% of NOH). In NOH, both BRSa 1 and α-BRSa were lower compared to the other patient populations (p<0.01), yet only α-BRSa was significantly lower compared to the Control group (p<0.05). Moreover, value of experimental β-BRSa was much larger in NOH compared to all other groups (p<0.01; Table 2 ). Only in Control group BRSa 1 correlated to VR (Table   5 ).
Baseline beat-to-beat BP recordings revealed 60% of the NOH population had supine hypertension (>140 mmHg), which corresponded to a significantly higher mean SBP compared to all other groups (p<0.05). In response to VM, NOH patients had the largest drop in SBP during phase II E ["A"], which translated into a significantly longer arrest time ["t 1 "] compared to the other groups (p<0.001, Tables 3   and 4 ). Only within NOH and Control groups did this drop in SBP significantly correlate with the SBP fall in HUT (Table 5 ). In Control group "A" also correlated to VR (Table 5 ). The SBP overshoot ["E"] seen in phase IV, was significantly lower in NOH compared to the other patient populations but not compared to Controls. Additionally, "A" and "E" were significantly correlated inversely within NOH and unilaterally within Control group ( Tables 3 and 4) . Overall, insufficient hemodynamic response in VM featured a V-shaped (or "V") pattern with a prolonged hyper-dip in phase II E followed by a "Syncline" instead of a "Valley" and a significantly delayed or completely absent PRT in phase IV (Table 4 , Figure 3 ). The "V" pattern was reproducible as there were no significant differences accordingly to the pairwise comparison of "A", "t 2 " and PRT obtained from a second trail within subjects (Table 6 ). The NOH patients, who could not complete the second VM trail, demonstrated a clear V-shaped SBP response as well.
Postural tachycardia syndrome
Main characteristics of population and autonomic findings. Compared to all OI patients, POTS and IST were significantly younger (p<0.01) and mainly females (p>0.05). POTS patients had greater body mass index compared to the Control only, whereas IST patients had greater body mass index compared to the all groups (Table 1) . POTS and IST did not differ from Control in terms of CASS /its individual indexes (Table 1) .
Quantitative HUT and VM analyses. HUT results and VR of POTS and IST patients did not differ from
Control either (Table 1) . Nonetheless, BRSa 1 was higher in POTS against Control (Table 2) . Only within POTS and Control groups did BRSa 1 correlate to the overshoot "E", α-BRSa, and β-BRSa (Table 5 ). Similar to SOI and Control groups, α-BRSa correlated to β-BRSa (Table 5 ; Figure 2 ).
VM patterning. One out 25 POTS patients and two out 6 IST patients did not perform the second trail of VM. VM responses in POTS and IST appeared analogous; yet, with closer visual inspection, two hemodynamic spikes "C" (SBP increments in phase II L ) and "E" (overshoot in phase IV) distinguished IST.
First, POTS presented different patterns (12 AAR, 11 BAR and 2 SAR), while IST was mostly AAR (aka 5
patterns with "C" rise over baseline, though one was BAR). Also, IST had higher incline "C" than the Control group (p<0.05), but not against POTS (Table 3) . Second, POTS had a relatively sustained decline of "E" from its peak (non-dropping ≥ 10 mmHg by 7 s at the average; Table 6 ); though, there was no clear overshoot "E" in 1 POTS patient (BAR). Conversely, IST showed a rapid SBP dip below baseline in majority (n=4/6) of participants or SBP drop of ≥ 10 mmHg in the rest of group within 3.5 s (Table 6 ; Figure 3 ). Overall, in IST prominent spikes "C" (rising over the baseline) and "E" (rapidly declining)
represented an M-shaped ("M") pattern compared to POTS, where prolonged decline of "E" was relatively perceived as an N-shaped ("N") pattern (Figure 3 ).
To evaluate reproducibility of "M" and "N" patterns we conducted a one-way repeated ANOVA (rANOVA). Measured differences between trail 1 and trail 2 within subject's VM were presence of AAR type of overshoot "E" and time of E decline over 10 mmHg or to the baseline. The results of rANOVA indicated no pairwise differences within subjects for time of "E" decline but for AAR pattern constancy in a repeated VM trail for both IST (n=4) and POTS (n=22) groups. Pairwise comparison between subjects of these factors involved in shaping of "M" and "N" patterns demonstrated significant differences (Table   6 ).
Symptomatic orthostatic intolerance
Main characteristics of population and autonomic findings. Patients with SOI did not differ by demographic characteristics. SOI presented with a greater adrenergic index (p<0.05) compared to
Control and a higher CASS than POTS (Table 1) .
Quantitative HUT and VM analyses In HUT, ΔHR was significantly lower in SOI compared to POTS (Table   2 ) and correlated to BRSv (Table 5) . Compared to Control, BRSa 1 was higher in SOI, as well in IST and POTS, while α-BRSa had the highest value only in IST ( Table 2 ). In SOI and Control groups, α-BRSa correlated to β-BRSa (Table 5 ; Figure 2 ). SOI showed greater SBP drop "A" compared to the Control group (p<0.05) and lower overshoot "E" compared to IST (p<0.005, Table 3 ).
VM patterning. Overall, compared to Control group (43 BAR, 30 AAR and 16 SAR), the SOI VM patterns were unremarkable, though absent SAR patterns (11 BAR patterns and 3 AAR).
DISCUSSION
The present study examined VM parameters (qualitative vs. quantitative) in specific clinical conditions (SOI, POTS and NOH vs. Control group and IST)) to extend previous findings obtained in healthy subjects
to that in dysautonomia characterized by OI (24) . Our results support the following conclusions: i) In OI, VM is a valuable supplement to HUT; ii) In VM, qualitative analysis may provide significant benefit to aid diagnosis; iii) In BRSa, separate alpha-and beta-adrenergic evaluation may improve autonomic screening.
First, our results demonstrate VM patterns are valuable non-orthostatic supplement to HUT given its capacity to detect OI and differentiate non-postural autonomic dysfunction. For example, post late phase IV BP changes in IST ("M" pattern) versus POTS ("N" pattern; Figure 3 ). We further explain this capacity by the presence of significant unilateral correlations among hemodynamic (∆SBP and "A", that is consistent with α-adrenergic response) and cardiac (∆HR and "VR", that is consistent with vagal response) alterations in VM and HUT in healthy populations (Control group). In NOH, the significance of the associations between postural (∆SBP) and non-postural ("A") hemodynamic falls is strengthened with adrenergic impairment (Figure 2 ). As well, low VR and ∆HR in NOH were associated with low adrenergic modulation (BRSa), which may indicate a reduced adrenergic control of HR in NOH patients.
As a result, NOH presents with a well-known hemodynamic response to VM, which we term a "V" pattern per its reproducibility in repeated VM trails within subjects. Specifically, the main features of the "V" pattern such as decreased phase II E ["t 2 "] and prolonged PRT did not differ in a repeated VM trail within NOH subjects (Table 5 ). Though NOH was significantly older population compared to the all groups and there might be potential group characteristics (e.g., physical activity status), only adrenergic failure contributes into both phase II L reduction /absence and prolonged PRT over 6 s (22) , which were found only in NOH. We claim that HUT, as a primary diagnostic tool in OI, will benefit from analyses of VM patterns, which provide instant visual markers, to monitor OI in a dynamic (e.g., recovery of phase II L and/or lesser PRT/greater overshoot in phase IV would indicate α-and/or β-adrenergic improvement respectively, which may not be figured out of single ∆SBP). This addition is important given the severity of NOH is linked to BRS insufficiency and a greater 4-year mortality rate (21, 27) . Similarly, VM analysis is a diagnostic aid in postural tachycardia when clinical symptoms are in question. The "M" pattern alone might be similar to AAR pattern and, likewise, contributed by the younger age and higher training status. However, prolonged to over 7 s duration of "E" overshoot decline of ≥10 mmHg or to the baseline level, which is reproducible within POTS subjects but significantly different between POTS and IST groups in repeated VM trails (Table 6 ) would rather confirm POTS in instances of postural tachycardia. We hypothesize that the "N" pattern is due to β-adrenergic hypersensitivity as it is shaped by relatively sustained overshoot in phase IV ("E"). Moreover, only in POTS and Control group did "E" correlate to BRSa (BRSa 1 ), which exposed greater link to β-BRSa within POTS but greater link to α-BRSa within the Control. However, further studies are necessary for the clarifications(1) and validation of α-and β-BRS calculations with muscle sympathetic neuronal activity and pharmacological dissection.
Second, visualization of VM patterns allows instant evaluation of potential clinically important findings
but not quantitative measures, which break down with OI progression (i.e. NOH). For an example, both α-and β-adrenergic insufficiency in NOH were featured by the "V" pattern. In contrast, parasympathetic impairment in NOH was not recognized by BRSv; as well, BRSa 1 did not reveal significant adrenergic insufficiency in NOH compared to the healthy subjects. As we did expect BRSv in NOH to be significantly different from Control given the differences in the VR and Δ HR, we further studied the potential impact of central and peripheral autonomic failure addressing that BRS pathways, which are involved in vasopressin release, are impaired in multiple system atrophy but are normal in pure autonomic failure (13) . However, the results revealed that BRSv values among the NOH subgroups groups were still insignificant. Thus, we suggest that classic calculation of BRSv may be an inappropriate measure applied to VM. First, classic calculation of BRSv is not focused on the R-R interval response to the BP rise following phase III, even though it is important(33) (mainly with regards to NOH, were both phases II E and IV are severely altered with a "V" pattern). Second, hemodynamic responses to VM are instant; thus, in those healthy individuals with excessively rapid changes in BP (>50 mmHg over a few seconds)
estimated BRSv values might be relatively low due to missed/unrecorded BP fluctuations(33).
The BRSa evaluation was compromised in pathological VM patterns (i.e., BRSa 1 was not applicable to (Tables 1 and 2 This may also explain the significantly augmented β-BRSa in NOH compared to the all other groups, which is in agreement with Tamura et al. study (32).
We would conclude that VM provides valuable qualitative evaluation in OI while BRSa evaluation is compromised and not as informative. We recommend BRSa calculation requires distinct, alpha and beta adrenergic assessment in VM. Avoiding the general BRSa description may enhance BRS accuracy, which is important for both autonomic research and clinical evaluation.
Perspectives and Significance
Present study shows that postural BP responses are implicated in specific BP patterns during VM.
Hemodynamic responses to VM in orthostatic dysfunction are probably associated with adrenergic BRS, which estimation is often compromised in autonomic impairment. However, qualitative BP patterning allows VM utilization beyond compromised quantification. If validated, VM patterning would improve the diagnosis of orthostasis, or potentially broaden the research window when HUT is limited.
Study limitation
The present study is limited to the biases of selection, confounding and information. Selection bias, which is prevalent in cross-sectional studies (7), is due to the mostly younger aged control population, relatively small IST sample size and a female predominance in IST and POTS groups. As age and gender of the subjects might have a considerable bearing on hemodynamic responses to VM and HUT, there is a confounding bias. To a certain degree, the physical activity status would have some effects on the VM responses given the evidence supports beneficial cardiovascular adaptations to training. Our subjects' physical activity levels were not recorded. However, the studies demonstrate that BRSa (which is associated with VM patterns in healthy population (24)) is not altered with both aerobic conditioning and resistance training (5, 6, 15) . In contrast, BRSv is increasing after 4 weeks of cycling but remains unchanged after 8 weeks of high-intensity strength training (5, 6, 15 ). Yet BRSv does not differ among those patients groups, associated potential fitness impact (unlikely in NOH where BP responses have rather classic features) has to be studied further.
Finally, information bias in the cohort study is necessitating further large sample sizes and long follow- D -SBP increment during PRT; E -SBP overshoot in phase IV; k α -α-adrenergic coefficient "rise of C over t 2 " as a hypotenuse adjusted to angle α; kȳ -β-adrenergic coefficient "rise of D over PRT" as hypotenuse adjusted to angle β; "Overshoot"-the peak of SBP recovery in phase IV; PRT -pressure recovery time in phase IV; "Rise"-the peak of SBP incline in late phase II; t 1 -duration of early phase II; 0.00 ± 0.00
Values are means ± standard deviation. * -significantly different from NOH (p<0.01); † -significantly different from SOI (p<0.05); ‡ -significantly different from IST (p<0.05); § -significantly different from Control (p<0.05); a -CASS was generated only for individuals presented with all three autonomic indices; b -Control n=88, POTS n=8, IST n=3, SOI n=4, and NOH n=5. 1 NOH patient was excluded from BRSv analysis due to potential artifact effect on SBP curve in early phase II. Abbreviations: "A" -Decrement in early phase II; BRSa 1 , alternative adrenergic BRS; α-BRSa, α-adrenergic BRS; β-BRSa, β-adrenergic BRS; BRSv, vagal BRS; Control -healthy population (n=107); ΔHR, heart rate change; ΔSBP, systolic blood pressure change; "E" -Overshoot in phase IV; IST, inappropriate sinus tachycardia (n=6); NOH, neurogenic orthostatic hypotension (n=25); POTS, postural tachycardia syndrome (n=25); SBP, systolic blood pressure; SOI, symptomatic orthostatic intolerance (n=13). The table presents results of a one-way repeated ANOVA in postural tachycardia syndrome (POTS), IST (sinus tachycardia) and neurogenic orthostatic hypotension (NOH). Measured differences between trail 1 and trail 2 of VM were: 1) Factor "AAR" -presence of augmented autonomic response; 2) Factor "E" -duration of overshoot "E" (in phase IV) decline over 10 mmHg or to the baseline; 3) Factor "t 2 " -duration of late phase II; 4) Factor "PRT" -pressure recovery time; 5) Factor "A" -decrement in early phase II. Symbols: * -the factor "E" analysis did not include one IST patient per possible artifact in phase IV. Symbols: * -significantly different multivariate effect between subjects (p<0.05); † -significantly different multivariate effect within subjects (p<0.05).
